Facebook
X
LinkedIn
Forward| Title | Credit |
Series date |
Member price | Non-member price |
|---|---|---|---|---|
|
Childhood Obesity SIG Course Bundle In this course bundle, three courses have been selected by the Childhood Obesity Prevention Special Interest Group (CO SIG) to increase knowledge related to AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care. |
05/16/2025 to 05/31/2026 | $0.00 | $0.00 | |
|
Guidance for Primary Care PNPs During and After Medical/Surgical Treatment of Obesity in Adolescents 1.0 NAPNAP contact hour. This continuing education activity is offered FREE to Members and Nonmembers. The American Academy of Pediatrics (AAP) recently released the ‘Clinical Practice Guideline (CPG) for the Evaluation and Treatment of Children and Adolescents with Obesity’ in early 2023. Updated from the AAP’s 2008 recommendations for prevention, assessment, and treatment of children and adolescents with overweight and obesity, the 2023 CPG offers expanded treatment recommendations which includes medication and surgical management. Pediatric Nurse Practitioners (PNP) may not understand the long-term management and support needs in primary care needed for this population. Discussion of management considerations for the primary care provider include: preventative care and screenings, health promotion, nutrition, body image, physical activity and psychological support. Additionally, recommendations for family and community involvement to support improved long-term care outcomes will be discussed. |
|
05/17/2024 to 05/31/2026 | $0.00 | $0.00 |
|
Clinical Updates in Pediatric Food Allergy Management Pediatric nurse practitioners and others who care for children with FA will benefit from a review of the immunopathophysiology and diagnosis of immunoglobulin E (IgE)-mediated FA and available therapies and data related to the use of biologic therapy in this disease. Experts will discuss the key aspects of FA management and contextualize the information in nurse practitioners’ role in important patient and caregiver conversations and care. |
|
05/15/2025 to 05/15/2026 | $0.00 | $0.00 |
|
JPHC CE: Approaches to Treating Children With ADHD and Common Comorbidities 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted. J Pediatr Health Care. (2025) 39, 318-325. |
|
03/01/2025 to 04/30/2026 | $0.00 | $10.00 |
|
JPHC CE: Preventing Suicide Through Lethal Means Restriction in Pediatric Care 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. This article explores the data and practice evidence for lethal means restriction and counseling, focusing on clinical strategies and policy changes to reduce access to lethal means. Emphasis is given to how pediatric providers speak with parents about the importance of restricting access when developing a safety plan. J Pediatr Health Care. (2025) 39, 308-317. |
|
03/01/2025 to 04/30/2026 | $0.00 | $10.00 |
|
2025 Immunization Update 1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines. |
|
04/07/2025 to 04/30/2026 | $0.00 | $12.50 |
|
Stop Child Trafficking in Your Community: Become an ACT Advocate (2024) 1.5 NAPNAP Contact Hours. This continuing education activity rate is $30 for NAPNAP Members and for non- members. This life-saving, innovative workshop and leadership opportunity is specifically developed for pediatric focused NPs to learn about child trafficking, methods of identification and referral and, most importantly, prevention. There are more people enslaved in labor and/or sex trafficking than at any point in history, meaning children of all socio-economic profiles are at risk with some populations more vulnerable than others. Alliance for Children in Trafficking (ACT) Advocates will receive a certificate of recognition as a trained expert who will then be able to deliver this unique content to health care professionals and lay people in your community. |
|
03/21/2024 to 03/31/2026 | $30.00 | $30.00 |
|
JPHC CE: Gene Therapy: A New Hope in Sickle Cell Disease Treatment 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sickle cell disease (SCD) is a lifelong disease requiring expensive treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients aged greater than 12 years. Consideration must be considered regarding the ethics, efficacy, management requirements, education, and counseling needs of patients and their parents. Current and future practices will need to advocate for improved access and affordability of this specialized care and address the unknown and less defined areas of gene therapy pertaining to SCD through research. J Pediatr Health Care. (2025) 39, Issue 1, 122-128. |
|
01/01/2025 to 02/28/2026 | $0.00 | $10.00 |
|
PIDS: Antimicrobial Stewardship for Advanced Practice Providers 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will highlight the key concepts related to antimicrobial stewardship for Advanced Practice Providers in the outpatient environment. Learn the core strategies to combat the threat of antimicrobial resistance. Improving antibiotic use amongst all providers is a key component in reducing inappropriate antimicrobial use and antibiotic resistance. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Group A Streptococcal Pharyngitis 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of Group A Streptococcus. Learn about the importance of utilizing the Modified Centor Score to determine when to test for Group A Strep. Review evidence for appropriate antibiotic treatment for Group A Strep. Apply this new knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Urinary Tract Infections 0.25 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of pediatric urinary tract infection in ambulatory care. Learn about the diagnosis and treatment of pediatric UTI. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Acute Sinusitis in Pediatrics 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of sinusitis in children in ambulatory care. This module will review the key differences between upper respiratory tract infections and sinusitis. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Skin and Soft Tissue Infections (SSTI) 0.25 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of skin and soft tissue infections in children. Review the key clinical diagnostic features for skin and soft tissue infections. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Clostridioides difficile 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of C.diff in children in ambulatory care. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |
|
PIDS: Community Acquired Pneumonia 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. This session will review evidence-based practice for the diagnosis and treatment of community acquired pneumonia in children in the ambulatory care environment. Apply this knowledge to clinical case scenarios. |
|
11/30/2023 to 12/31/2025 | $0.00 | $0.00 |